Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
CAS No. 184882-07-3
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside( ——— )
Catalog No. M39745 CAS No. 184882-07-3
Pelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionPelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
-
DescriptionPelargonidin3-O-[6-O-(E)-Caffeoyl-2-O-{6-O-(E)-Caffeoyl-β-D-glucoside}-β-D-glucoside]-5-glucoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number184882-07-3
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DDD100097
DDD100097 is a potent N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.
-
Influenza NP (482 - ...
Influenza NP (482 - 489)
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat is a potent antagonist of PACAP 38. PACAP (6-38) is much more potent and selective than PACAP (6-27) in the inhibition of PACAP-27-stimulated pituitary adenylate cyclase.
